Advertisement

Topics

Innovative Biotechnologies International Incorporated Company Profile

17:05 EDT 24th September 2018 | BioPortfolio

Innovative Biotechnologies International, Inc.,("IBI") was incorporated in 1994 to accelerate the transformation of technologies developed at U.S. universities. Since most university technologies require additional development effort as well as market analysis before commercial products can be made available, IBI has established a unique mechanism whereby the company can work with the universities and third party companies to achieve effective commercialization.

Location

335 Lang Blvd
Grand Isle
NY
14072
United States of America

Contact

Phone: 716-773-4232
Fax: 716-773-4257
Email: info@ibi.cc


News Articles [572 Associated News Articles listed on BioPortfolio]

AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands

NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company will b...

AXIM® Biotechnologies to Present at BIT’s 16th Annual Congress of International Drug Discovery Science and Technology

NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the Company will ...

Deals this week: Refuge Biotechnologies, Attenua, Crescendo Biologics

US-based Refuge Biotechnologies Inc has raised $25m in a series B funding round led by 3SBio and Sequoia China. The...Read More... The post Deals this week: Refuge Biotechnologies, Attenua, Crescendo ...

INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES

$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Aegea Biotechnologies' next generation nucleic acid clinical diagnostic technologies gets US, Australian & Chinese patents

Aegea Biotechnologies, a biotechnology company, announces the issuance of a collection of patents including US Patent 9,428,747 entitled methods for amplification of nucleic acids utilising hairpin lo...

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

SQZ Biotechnologies Closes Oversubscribed $72 Million Series C

Watertown, Massachusetts-based SQZ Biotechnologies completed an oversubscribed Series C financing worth $72 million. New investors included Everblue, Illumina Ventures, Invus, Orient Life, and Viva Ve...

PubMed Articles [783 Associated PubMed Articles listed on BioPortfolio]

Comment on "Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis".

Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy.

Despite its clinical promise, photodynamic therapy (PDT) suffers from a key drawback associated with its oxygen-dependent nature, which limits its effective use against hypoxic tumor. Moreover, both P...

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Endoscopy robotics: current and future applications.

Many different types of endoscopy robots have been developed or are under development. Some of these innovative biotechnologies are dedicated to complex endoscopic procedures as endoscopic submucosal ...

MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.

Currently, no outcome measures are clinically validated and accepted as clinical endpoints by regulatory agencies for drug development in intermediate age-related macular degeneration (iAMD). The MACU...

Clinical Trials [1657 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Cytomegalovirus (CMV) is the most common opportunistic viral pathogen in solid organ transplant receptors (SOTR). In Mexico, the experience using generic immunosuppressants have been demon...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Acquisition and Utilization of Skills Using Innovative Smartphone Application for Regular Eating

The study seeks to evaluate the acceptability, feasibility, target engagement, and validity of an innovative smartphone application with ecological momentary interventions to augment cogni...

Companies [1888 Associated Companies listed on BioPortfolio]

Innovative Biotechnologies International Incorporated

Innovative Biotechnologies International, Inc.,("IBI") was incorporated in 1994 to accelerate the transformation of technologies developed at U.S. universities. Since most university technologies req...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Ningbo Create Biological Project Co.,Ltd.

A complete integration of R&D of high-new biotechnologies, amino acids and series derivatives production as well as international and domestic marketing and sales service, Create is tracking the inter...

More Information about "Innovative Biotechnologies International Incorporated" on BioPortfolio

We have published hundreds of Innovative Biotechnologies International Incorporated news stories on BioPortfolio along with dozens of Innovative Biotechnologies International Incorporated Clinical Trials and PubMed Articles about Innovative Biotechnologies International Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innovative Biotechnologies International Incorporated Companies in our database. You can also find out about relevant Innovative Biotechnologies International Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record